{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:18:53Z","timestamp":1790381933211,"version":"4.1.0"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T00:00:00Z","timestamp":1609200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The performance of the galactomannan enzyme immunoassay (GM-EIA) is impaired in patients receiving mould-active antifungal therapy. The impact of mould-active antifungal therapy on Aspergillus PCR testing needs to be determined.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>To determine the influence of anti-mould prophylaxis (AMP) on the performance of PCR blood testing to aid the diagnosis of proven\/probable invasive aspergillosis (IA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>As part of the systematic review and meta-analysis of 22 cohort studies investigating Aspergillus PCR blood testing in 2912 patients at risk of IA, subgroup analysis was performed to determine the impact of AMP on the accuracy of Aspergillus PCR. The incidence of IA was calculated in patients receiving and not receiving AMP. The impact of two different positivity thresholds (requiring either a single PCR positive test result or \u22652 consecutive PCR positive test results) on accuracy was evaluated. Meta-analytical pooling of sensitivity and specificity was performed by logistic mixed-model regression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 1661 (57%) patients received prophylaxis. The incidence of IA was 14.2%, significantly lower in the prophylaxis group (11%\u201312%) compared with the non-prophylaxis group (18%\u201319%) (P\u200a&amp;lt;\u200a0.001). The use of AMP did not affect sensitivity, but significantly decreased specificity [single PCR positive result threshold: 26% reduction (P\u200a=\u200a0.005); \u22652 consecutive PCR positive results threshold: 12% reduction (P\u200a=\u200a0.019)].<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Contrary to its influence on GM-EIA, AMP significantly decreases Aspergillus PCR specificity, without affecting sensitivity, possibly as a consequence of AMP limiting the clinical progression of IA and\/or leading to false-negative GM-EIA results, preventing the classification of probable IA using the EORTC\/MSGERC definitions.<\/jats:p><\/jats:sec>","DOI":"10.1093\/jac\/dkaa498","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T16:59:40Z","timestamp":1608310780000},"page":"635-638","source":"Crossref","is-referenced-by-count":32,"title":["The impact of anti-mould prophylaxis on<i>Aspergillus<\/i>PCR blood testing for the diagnosis of invasive aspergillosis"],"prefix":"10.1093","volume":"76","author":[{"given":"M","family":"Cruciani","sequence":"first","affiliation":[{"name":"Azienda ULSS 9 Scaligera, Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P L","family":"White","sequence":"additional","affiliation":[{"name":"Public Health Wales, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Mengoli","sequence":"additional","affiliation":[{"name":"University of Padua, Padua, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"L\u00f6ffler","sequence":"additional","affiliation":[{"name":"University of Wuerzburg, Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C O","family":"Morton","sequence":"additional","affiliation":[{"name":"Western Sydney University, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Klingspor","sequence":"additional","affiliation":[{"name":"Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Buchheidt","sequence":"additional","affiliation":[{"name":"Heidelberg University, Mannheim, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Maertens","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology, and Transplantation, KULeuven, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W J","family":"Heinz","sequence":"additional","affiliation":[{"name":"University of Wuerzburg, Wuerzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T R","family":"Rogers","sequence":"additional","affiliation":[{"name":"Trinity College Dublin, St James\u2019s Hospital Campus, Dublin, Ireland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Weinbergerova","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine \u2013 Haematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Warris","sequence":"additional","affiliation":[{"name":"MRC Centre for Medical Mycology, University of Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D E A","family":"Lockhart","sequence":"additional","affiliation":[{"name":"University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Jones","sequence":"additional","affiliation":[{"name":"Institute of Infection, Immunity and Inflammation, University of Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Cordonnier","sequence":"additional","affiliation":[{"name":"Hopital Henri Mondor, Creteil, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8521-335X","authenticated-orcid":false,"given":"J P","family":"Donnelly","sequence":"additional","affiliation":[{"name":"University of Nijmegen, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A","family":"Barnes","sequence":"additional","affiliation":[{"name":"Cardiff University School of Medicine, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Fungal PCR Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Klingspor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Buchheidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Maertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W J","family":"Heinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T R","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Weinbergerova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Warris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D E A","family":"Lockhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Cordonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J P","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,29]]},"reference":[{"key":"2021021208595608300_dkaa498-B1","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1086\/429921","article-title":"Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay","volume":"40","author":"Marr","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2021021208595608300_dkaa498-B2","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/cid\/ciu673","article-title":"Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis","volume":"59","author":"Duarte","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021021208595608300_dkaa498-B3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/jcp.2011.090464","article-title":"Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis","volume":"65","author":"McCulloch","year":"2012","journal-title":"J Clin Pathol"},{"key":"2021021208595608300_dkaa498-B4","first-page":"CD009551","article-title":"Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people","volume":"9","author":"Cruciani","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2021021208595608300_dkaa498-B5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1086\/323335","article-title":"Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus","volume":"34","author":"Ascioglu","year":"2002","journal-title":"Clin Infect Dis"},{"key":"2021021208595608300_dkaa498-B6","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"2021021208595608300_dkaa498-B7","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021021208595608300_dkaa498-B8","doi-asserted-by":"crossref","DOI":"10.1002\/9780470693926","volume-title":"Systematic Reviews in Health Care. Meta-Analysis in Context","author":"Egger","year":"2001","edition":"2nd edn"},{"key":"2021021208595608300_dkaa498-B9","volume-title":"Manual of Epidemiology for District Health Management","author":"Vaughan","year":"1989"},{"key":"2021021208595608300_dkaa498-B10","first-page":"CD007394","article-title":"Galactomannan detection for invasive aspergillosis in immunocompromised patients","volume":"30","author":"Leeflang","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2021021208595608300_dkaa498-B11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1086\/510535","article-title":"Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy","volume":"195","author":"Hope","year":"2007","journal-title":"J Infect Dis"},{"key":"2021021208595608300_dkaa498-B12","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciw444","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2021021208595608300_dkaa498-B13","article-title":"Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline","volume":"24 Suppl 1","author":"Ullmann","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2021021208595608300_dkaa498-B14","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1093\/jac\/dks208","article-title":"Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies","volume":"67","author":"Reinwald","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2021021208595608300_dkaa498-B15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1600-0609.2010.01452.x","article-title":"Aspergillus PCR testing: results from a prospective PCR study within the AmBiLoad trial","volume":"85","author":"Hummel","year":"2010","journal-title":"Eur J Haematol"},{"key":"2021021208595608300_dkaa498-B16","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/MPH.0b013e3181b83e77","article-title":"Prospective monitoring for invasive aspergillosis using galactomannan and polymerase chain reaction in high risk pediatric patients","volume":"31","author":"Armenian","year":"2009","journal-title":"J Pediatr Hematol Oncol"},{"key":"2021021208595608300_dkaa498-B17","doi-asserted-by":"crossref","first-page":"5517","DOI":"10.1128\/JCM.42.12.5517-5522.2004","article-title":"Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid","volume":"42","author":"Musher","year":"2004","journal-title":"J Clin Microbiol"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/76\/3\/635\/36241102\/dkaa498.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/76\/3\/635\/36241102\/dkaa498.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T14:42:10Z","timestamp":1724078530000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/76\/3\/635\/6055077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,29]]},"references-count":17,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,12,29]]},"published-print":{"date-parts":[[2021,2,11]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaa498","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,3,1]]},"published":{"date-parts":[[2020,12,29]]}}}